title: Investigator-Reported Bleeding Versus Post Hoc Adjudication of Bleeding: Lessons From the CHAMPION PHOENIX Trial.
authors: Tannas
authors: T
authors: Jatene
authors: Robert A
authors: RA
authors: Harrington
authors: Gregg W
authors: GW
authors: Stone
authors: Ph Gabriel
authors: PG
authors: Steg
authors: C Michael
authors: CM
authors: Gibson
authors: Christian W
authors: CW
authors: Hamm
authors: Matthew J
authors: MJ
authors: Price
authors: Jayne
authors: J
authors: Prats
authors: Efthymios N
authors: EN
authors: Deliargyris
authors: Kenneth W
authors: KW
authors: Mahaffey
authors: Harvey D
authors: HD
authors: White
authors: Deepak L
authors: DL
authors: Bhatt
mesh_terms: D000249:Adenosine Monophosphate / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D009203:Myocardial Infarction / Q000628:therapy*; D062645:Percutaneous Coronary Intervention / Q000379:methods; D058921:Purinergic P2Y Receptor Antagonists / Q000008:administration & dosage / Q000009:adverse effects; D016032:Randomized Controlled Trials as Topic; D012107:Research Design / Q000706:statistics & numerical data
chemical_list: D058921:Purinergic P2Y Receptor Antagonists; D000249:Adenosine Monophosphate; C117446:cangrelor